Further study explored the mechanism of ABCG2 expression in HCC, demonstrating by altering the subcellular localization of ABCG2 that the Akt pathways regulated the SP phenotype activity and the ABCG2-induced chemotherapy resistance could be resisted via inhibited Akt signaling [93, 96]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.